Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell-lung cancer: an observational study
Document ID: RD-110477, 01/06/2019
Author: Boehringer Ingelheim
Document ID: RD-110477, 01/06/2019
Author: Boehringer Ingelheim